Mirae Asset Global Etfs Holdings Ltd. Celldex Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 39,388 shares of CLDX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,388
Previous 43,451
9.35%
Holding current value
$1.04 Million
Previous $788,000
1.65%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CLDX
# of Institutions
198Shares Held
68.2MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$161 Million14.83% of portfolio
-
Wellington Management Group LLP Boston, MA5.23MShares$138 Million0.02% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$124 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$105 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.82MShares$101 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.24B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...